News | May 10, 2022
Sun gets 10 observations from USFDA for Halol facility
The company is preparing the response to the observations, which will be submitted to the USFDA within 15 business days
The company is preparing the response to the observations, which will be submitted to the USFDA within 15 business days
Upon closing, the Quakertown business will become an independent company called Microsize
The new hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year
The inspection report contains no 'critical' observations and only one of the deficiencies is categorized as 'major' which is being addressed expeditiously in consultation with the regulatory agency
The management believes that its strong product pipeline, diversified innovative product portfolio, continued expansion into new geographies and FGMP accreditations will help sustain the growth momentum in the coming few years
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
Under the terms of the agreement, Bachem will provide the appropriate engineering infrastructure and expertise to implement Lilly’s novel oligonucleotide manufacturing technology
The business is a recognized leader in managing Covid-19 and mRNA research programs
Bionova Scientific’s process development capabilities are particularly highly regarded in the industry, and it has a rich track record regarding complex next-generation antibody drugs, which are typically challenging to manufacture
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
Subscribe To Our Newsletter & Stay Updated
